XORTX Therapeutics (ANUA.F) Q4 2024 Earnings

14NovConfirmed
Q2 2024
Q3 2024
Q4 2024
-1.14
-0.74
-0.34
0.05

Details

Expected EPS
-0.36384133648
Actual EPS
-0.27540139999999996
Surprise EPS
0.09
Surprise Percent
+24.31%

Description

XORTX Therapeutics (ANUA.F) has reported earnings of -0.27540139999999996 per share for Q4 2024.

0 Comments

Share your thoughts